McKesson Corporation – Consensus Indicates Potential 5.4% Upside McKesson Corporation with ticker code (MCK) have now 13 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 409 and 320 calculating the average target price we see 380.46. With the stocks previous close at 360.8 this would indicate that there is a potential upside of 5.4%. The day 50 moving average is 344.61 and the 200 day MA is 297.73. The company has a market capitalisation of $52,743m. Find out more information at: https:||www.mckesson.com [stock_market_widget type="chart" template="basic" color="green" assets="MCK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $55,617m based on the market concensus. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S.